Researchers have been excited about the medication , a novel dual compound showing significant outcomes in initial trials for body loss . It works by targeting two pathways : GLP-1 and GIP, which , https://jayafjwf449640.uzblog.net/this-new-possibility-for-size-reduction-54415666